XML 40 R25.htm IDEA: XBRL DOCUMENT v3.22.2.2
Financial Instruments and Derivatives (Tables)
9 Months Ended
Sep. 30, 2022
Fair Value Disclosures [Abstract]  
Effect of Derivative Instruments on Consolidated Statement of Operations

The tables below present the effect of the Company’s derivative financial instruments on the Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2022 and 2021 (dollars in thousands):

 

 

 

 

Net Loss Reclassified from AOCL into Interest Expense

 

 

 

Location of Loss Reclassified

 

Three months ended September 30,

 

Derivatives in Cash Flow Hedging Relationships

 

from AOCL into Income

 

2022

 

 

2021

 

Terminated interest rate swaps

 

Interest expense

 

$

(279

)

 

$

(278

)

 

 

 

 

Nine months ended September 30,

 

 

 

 

 

2022

 

 

2021

 

Terminated interest rate swaps

 

Interest expense

 

$

(835

)

 

$

(835

)

 

 

 

 

 

(Loss) Gain Recognized in Earnings on Derivative

 

 

 

Location of (Loss) Gain Recognized

 

Three months ended September 30,

 

Derivative Not Designated as Hedging Instrument

 

in Earnings on Derivative

 

2022

 

 

2021

 

Preferred stock embedded derivative

 

Other non-operating expense (income)

 

$

(425

)

 

$

13,432

 

 

 

 

 

Nine months ended September 30,

 

 

 

 

 

2022

 

 

2021

 

Preferred stock embedded derivative

 

Other non-operating expense (income)

 

$

(10,364

)

 

$

11,492